Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma

Anuvrat Sircar, Lalit Sehgal, Ken H. Young et al.|Leukemia|2023

Cited by 13